Home/ Supplements/ Ginkgo/ Cogni-Flex

Cogni-Flex

product on market Capsule Douglas Laboratories Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 50% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Cogni-Flex contains ingredients like ginkgo biloba and phosphatidylserine, which are researched for their roles in supporting cognitive function and memory. Evidence for these components varies from moderate to limited in clinical settings. The formulation utilizes acetyl-L-carnitine and huperzine A to target neurotransmitter activity and brain health.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Cogni-Flex
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Capsule(s)
Serving Size
60
Servings
Other Combinations
Product Type
50%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Market median: 120.0mg (440 products) 191 studies (A:1, B:71)
Market median: 100.0mg (108 products)
Market median: 500.0mg (861 products) 61 studies (A:4, B:13)
100 mcg
Market median: 0.15mg (41 products)

Other Ingredients

Microcrystalline Cellulose Gelatin Vegetable Stearate Silica
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested Usage: Adults take 1 capsule daily or as directed by a health professional.

Warnings & Precautions

Warning: If you are pregnant, nursing, have any health condition or taking any medication, consult your health professional before using this product.

Keep out of the reach of children.

Use only if safety seal is intact.

Contains: Soy

Formulation Notes

Gluten-free, Non-GMO

Cognitive and neurological health

Additional Information

Store in a cool, dry place.

Scan to learn about our manufacturing excellence Contents may not fill package in order to accommodate required labeling. Please rely on stated quantity.

Metadata

Product Details

UPC / SKU3 10539 00903 1
DSLD Entry Date2020-08-23
Product TypeOther Combinations
FormCapsule
DSLD ID232026
Data Updated2026-04-11
Research

Research Evidence

183
Research Sources
55
Avg Quality
86
Systematic Review
78
Meta Analysis
7
Other
4
Clinical Trial
2
Rct
2
Narrative Review
2
Regulatory Source
1
Openfda Safety
A Ginkgo biloba for cognitive impairment and dementia
Meta Analysis The Cochrane database of systematic reviews 2026 PubMed DOI
B Ginkgo biloba for cognitive impairment and dementia
Meta Analysis The Cochrane database of systematic reviews 2009 PubMed DOI
B Ginkgo biloba for tinnitus
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
B Ginkgo biloba for tinnitus
Systematic Review The Cochrane database of systematic reviews 2022 PubMed DOI
B Ginkgo biloba for prevention of dementia: a randomized controlled trial
Rct JAMA 2008 PubMed DOI
B Effectiveness and safety of ginkgo biloba preparations in the treatment of Alzheimer's disease: A systematic review and meta-analysis
Systematic Review Frontiers in aging neuroscience 2023 PubMed DOI
B Ginkgo biloba for intermittent claudication
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
B The Comparative Efficacy of Multiple Interventions for Mild Cognitive Impairment in Alzheimer's Disease: A Bayesian Network Meta-Analysis
Systematic Review Frontiers in aging neuroscience 2020 PubMed DOI
B Comparative effects of Bacopa monnieri and Ginkgo biloba on cognitive functions: A systematic review and network meta-analysis
Meta Analysis Phytomedicine : international journal of phytotherapy and phytopharmacology 2026 PubMed DOI
B Ginkgo biloba for intermittent claudication
Meta Analysis The Cochrane database of systematic reviews 2009 PubMed DOI
View all evidence for Ginkgo →
Compare

Similar Products

View all Ginkgo products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.